Citation Impact
Citing Papers
Cost of Relapse in Schizophrenia
1995
Depression
2018 Standout
Review on plant antimicrobials: a mechanistic viewpoint
2019 Standout
Age of onset of mental disorders: a review of recent literature
2007 Standout
A new taxonomy for describing and defining adherence to medications
2012 Standout
Targeting the dopamine D2receptor in schizophrenia
2006
Continuation and maintenance therapy with antidepressive agents
1991
The Use of Psychotropic Medications During Breast-Feeding
2001
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
1998 Standout
Early Termination of Antidepressant Drug Treatment
2000
Reversal of Multidrug Resistance by 7-O-Benzoylpyripyropene A in Multidrug-Resistant Tumor Cells.
2000 StandoutNobel
Albumin–drug interaction and its clinical implication
2013 Standout
Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function
2012
Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine
1992 Standout
Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed?
2005
A systematic review of the associations between dose regimens and medication compliance
2001 Standout
Drugs in Human Milk
1988
Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia
2002 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants
2004
Treatment of migraine
1992
Intra‐articular depot formulation principles: Role in the management of postoperative pain and arthritic disorders
2008
Compliance during treatment with antidepressants
1997
An Alternate Pathway for CD4 T Cell Development: Thymocyte-Expressed MHC Class II Selects a Distinct T Cell Population
2005
Modulating antibiotic activity towards respiratory bacterial pathogens by co-medications: a multi-target approach
2016
SOCS regulation of the JAK/STAT signalling pathway
2008 Standout
How stigma interferes with mental health care.
2004 Standout
Depression and Pain Comorbidity
2003 Standout
Extracorporeal circulation in the management of severe tricyclic antidepressant overdose
1994
Placebo-Controlled Continuation Treatment with Mirtazapine: Acute Pattern of Response Predicts Relapse
2004
Double-Blind, Placebo-Controlled Trial of the Use of Lithium to Augment Antidepressant Medication in Continuation Treatment of Unipolar Major Depression
2000
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Pharmacologic circumvention of multidrug resistance
1993
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
2002 Standout
Human Cannabinoid Pharmacokinetics
2007 Standout
Sleep and Psychiatric Disorders
1992 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Postpartum Depression: Current Status and Future Directions
2013 Standout
A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine)
1982 StandoutNobel
The Biology of NKT Cells
2006 Standout
Biochemical and Histochemical Studies on the Effects of Imipramine‐like Drugs and (+)‐Amphetamine on Central and Peripheral Catecholamine Neurons
1966 StandoutNobel
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma
2001
Drugs acting through dopamine release
1975 StandoutNobel
Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine‐resistant uptake mechanism of central and peripheral monoamine neuronesin vivoandin vitro
1969 StandoutNobel
Quantitative Evaluation of Release and Reuptake of Adrenergic Transmitter in the Rabbit Heart
1971
Biogenic Amines and Depression
1975 Standout
Plasma and Tissue Protein Binding of Drugs in Pharmacokinetics
1976
Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramine
1969 StandoutNobel
Physical symptoms of depression.
1981
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramine
1969 StandoutNobel
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
Increased Nerve Stimulation Induced Release of Noradrenaline from the Rabbit Heart after Inhibition of Prostaglandin Synthesis
1971 StandoutNobel
The effect of imipramine of central 5-hydroxytryptamine neurons
1968 StandoutNobel
The Prophylactic Efficacy of Fluoxetine in Unipolar Depression
1988
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents
1967
The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
1987 Standout
PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride
1987
Sleep and treatment prediction in endogenous depression
1981
Subjective Side-Effects of Amitriptyline and Lithium in Affective Disorders
1983
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Fluorine in health care: Organofluorine containing blockbuster drugs
2010 Standout
Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
1992 Standout
From the Selective Serotonin Transporter Inhibitor Citalopram to the Selective Norepinephrine Transporter Inhibitor Talopram: Synthesis and Structure−Activity Relationship Studies
2008
Part 14: Pediatric Advanced Life Support
2010 Standout
Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society.
1997 Standout
Antidepressant-induced mania and cycle acceleration: a controversy revisited
1995
(+)-AJ 76 and (+)-UH 232: Central stimulants acting as preferential dopamine autoreceptor antagonists
1986 StandoutNobel
Physical Symptoms of Depression
1981
Pharmacology of Synaptic Monoamine Transmission
1969 StandoutNobel
Metatyrosine as a tool for selective protection of catecholamine stores against reserpine
1967 StandoutNobel
Recent studies on the mode of action of antidepressive drugs
1967 StandoutNobel
Factors affecting therapeutic compliance: A review from the patient’s perspective
2008 Standout
Works of A. Jørgensen being referenced
Superantigens Are Presented by and Activate Thymocytes from Infants
1999
Prolonged Release from the Injection Site of Morphine from Morphine Esters in an Oil Vehicle Given by Intramuscular Injection to Pigs
1994
Continuation Therapy with Amitriptyline in Depression
1978
Pharmacological Studies of a New Series of Bicyclic Thymoleptics
1966
Amitriptyline and nortriptyline excretion in human breast milk
1982
The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation
2010
A depot neuroleptic withdrawal study neurological effects
1983
Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate
1982
The Distribution Pattern of a Series of Tricyclic and Bicyclic Thymoleptics Compared with their Lipophilic Properties and Binding to Plasma Proteins
1973
A clinical trial comparing sustained release amitriptyline (Saroten® Retard) and conventional amitriptyline tablets (Saroten®) in endogenously depressed patients with simultaneous determination of serum levels of amitriptyline and nortriptyline
1978
AMITRIPTYLINE PLASMA-CONCENTRATION AND CLINICAL EFFECT
1978